FirstCry's subsidiary Swara Baby files DRHP for IPO up to ₹10,000 Million
Swara Baby, a subsidiary of FirstCry, filed a DRHP for an IPO aiming to raise up to ₹10,000 million (₹1,000 crore). The IPO comprises a fresh issue of ₹5,000 million and an OFS of ₹5,000 million. Swara Baby's FY26 revenue was ₹11,639 million (₹1,163.9 crore).
The IPO of a subsidiary and the potential partial monetization of FirstCry's stake are significant corporate actions that could impact the parent company's valuation and financial structure.
The company is announcing the filing of a DRHP for its subsidiary's IPO, which is generally viewed as a positive step for unlocking value and future growth.
Brainbees Solutions Limited (FirstCry) announced that its subsidiary, Swara Baby Products Limited, has filed a Draft Red Herring Prospectus (DRHP) dated July 2, 2026, with SEBI, BSE, and NSE for an Initial Public Offering (IPO).
The proposed IPO aims to raise up to ₹10,000 million (approximately ₹1,000 crore). This includes a fresh issue of equity shares aggregating up to ₹5,000 million (approximately ₹500 crore) and an Offer for Sale (OFS) of equity shares aggregating to ₹5,000 million (approximately ₹500 crore). The face value of each equity share is ₹2.
Swara Baby, which began operations in 2018, was initially established to scale FirstCry's home brands in the diaper category and achieve backward integration. FirstCry made a primary investment of ₹906.17 million (approximately ₹90.617 crore) in 2020, acquiring a 53.45% stake, and has since increased its shareholding to 76.59%. Swara Baby has since diversified into adult diapers and sanitary napkins and has attracted business from various retailers and brand owners. Its revenue from operations for FY26 was ₹11,639 million (approximately ₹1,163.9 crore), with ₹9,004.39 million (approximately ₹900.439 crore) consolidated into FirstCry's multi-channel business after inter-company adjustments. The EBITDA for FY26 was ₹1,927.70 million (approximately ₹192.77 crore), with an adjusted consolidated EBITDA of ₹1,445.7 million (approximately ₹144.57 crore).
The rationale for Swara Baby's independent listing is its expansive and global vision in contract manufacturing of disposable hygiene products, which requires different capex and working capital needs compared to FirstCry's core business. This IPO represents a partial monetization of FirstCry's investment, allowing it to crystallize value and maintain flexibility for future strategic opportunities, while Swara Baby continues as a subsidiary. The terms of trade between the two companies will remain at arm's length post-listing. Mr. Alok Birla leads Swara Baby's operations, with Mr. Supam Maheshwari and Mr. Gautam Sharma appointed as non-executive directors on Swara Baby's board.
What to do with a filing like this
Brainbees Solutions Limited filed this with the NSE as a statutory disclosure, categorised under ipo. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Brainbees Solutions Limited. Read the original for the full detail.